CORCEPT THERAPEUTICS INC — Director's Dealing 2011

Sep 12, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-09-01

Reporting Person: Robb Gary Charles (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-09-01	Stock option (right to buy)	$2.70	A	600000	Acquired	2021-09-01	Common stock (600000)	Direct

Footnotes

F1: Exercisable with respect to 25% of the total number of Option Shares one year after 9/1/2011 and with respect to an additional 2.08334% of the total number of Option Shares on the monthly anniversary of 9/1/2011 each month thereafter.